Dulbecco's Modified Eagle Medium (DMEM) Medium Equipment Global Market Report 2025

The dulbecco’s modified eagle medium (DMEM) medium equipment market size has grown strongly in recent years. It will grow from $1.25 billion in 2024 to $1.36 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth observed in the historic period can be attributed to the rising demand for cell culture research, increased government funding for life sciences, growing awareness and adoption of stem cell research, expanding use of serum-free media, and a heightened focus on the development of cell-based therapeutics.

The dulbecco’s modified eagle medium (DMEM) medium equipment market size is expected to see strong growth in the next few years. It will grow to $1.87 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to the increasing adoption of advanced cell-based assays, rising investment in regenerative medicine, growing demand for precision medicine, expanding need for automated laboratory equipment, and the surging demand for innovative therapeutic approaches. Major trends anticipated during this period include technological advancements in culture media formulation, innovations in serum-free and chemically defined DMEM, progress in automated and robotic handling systems, increased research and development for high-efficiency media, and the integration of data analytics and monitoring technologies.

The rising demand for biological drugs is expected to drive the growth of the Dulbecco’s Modified Eagle Medium (DMEM) medium equipment market in the coming years. Biological drugs, which are derived from living organisms or their components such as proteins or antibodies, are increasingly used to treat complex conditions including cancer, autoimmune diseases, and genetic disorders. The growing global production of biologics is being fueled by the expanding healthcare infrastructure and the increasing focus on personalized and targeted therapies for chronic diseases. DMEM medium equipment supports this trend by ensuring precise media preparation, maintaining optimal physicochemical conditions, and enabling scalable cell-based production processes. For instance, in February 2025, the World Health Organization (WHO) reported that 81 biologic therapies were included in its Essential Medicines List, accounting for over 15% of all essential medicines. Thus, the increasing demand for biologics is contributing to the growth of the DMEM medium equipment market.

Rising investment in the biopharmaceutical sector is further boosting the DMEM medium equipment market. Growing financial support for the research, development, and commercialization of innovative therapeutic products is driven by the demand for advanced treatments targeting chronic and rare diseases. These investments are accelerating the adoption of modern cell culture technologies, including automated DMEM preparation systems and scalable bioprocessing solutions. For instance, in January 2025, the BioIndustry Association (BIA) announced that the UK biotech sector secured $4.3 billion USD (£3.5 billion) in investment in 2024, marking a 94% increase from the previous year. Such funding trends are strengthening infrastructure for advanced biologics production, thereby driving market expansion.

Major companies in the DMEM medium equipment market are focusing on technological innovation and automation to enhance process efficiency, consistency, and scalability in cell culture operations. Automated cell culture platforms integrate robotics and smart sensors to perform complex laboratory procedures with minimal human intervention, ensuring high reproducibility and throughput. For example, in May 2025, Multus Biotechnology Ltd., a UK-based biotechnology company, introduced DMEM/F12-FG, a food-grade basal medium designed specifically for cultivated meat production. Formulated with essential nutrients such as salts, sugars, and vitamins, this product meets food-grade compliance standards and supports scalable, sustainable manufacturing. Developed using AI-based optimization and global industry collaboration, this innovation underscores the growing intersection between biotechnology and sustainable food production, positioning advanced DMEM media systems as vital enablers in both biopharmaceutical and cellular agriculture applications.

Major players in the dulbecco’s modified eagle medium (DMEM) medium equipment market are Thermo Fisher Scientific Inc., Merck KGaA, FUJIFILM Irvine Scientific Inc., GE Healthcare Technologies Inc., Corning Incorporated, Lonza Group Ltd., Avantor Inc., Agilent Technologies Inc., Sartorius AG, Bio-Techne Corporation, MP Biomedicals LLC, HiMedia Laboratories Pvt. Ltd., Creative Bioarray Inc., Capricorn Scientific GmbH, US Biological Life Sciences Inc., PhytoTech Labs Inc., Alkali Scientific LLC, Genexis Biotech Pvt. Ltd., STEMCELL Technologies Inc., and Bioartha Labs Private Limited.

North America was the largest region in the dulbecco’s modified eagle medium (DMEM) medium equipment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in dulbecco’s modified eagle medium (DMEM) medium equipment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The dulbecco’s modified eagle medium (DMEM) medium equipment market research report is one of a series of new reports that provides dulbecco’s modified eagle medium (DMEM) medium equipment market statistics, including dulbecco’s modified eagle medium (DMEM) medium equipment industry global market size, regional shares, competitors with a dulbecco’s modified eagle medium (DMEM) medium equipment market share, detailed dulbecco’s modified eagle medium (DMEM) medium equipment market segments, market trends and opportunities, and any further data you may need to thrive in the dulbecco’s modified eagle medium (DMEM) medium equipment industry. This dulbecco’s modified eagle medium (DMEM) medium equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Dulbecco’s Modified Eagle Medium (DMEM) equipment refers to specialized laboratory systems designed for the preparation, handling, and maintenance of DMEM, a nutrient-dense formulation critical for supporting mammalian cell cultures. These systems ensure that the medium maintains its precise physicochemical balance, enabling consistent cell growth, metabolic activity, and experimental reliability in both research and biomanufacturing settings.

The primary types of DMEM medium equipment include cell culture equipment, bioreactors, filtration systems, centrifuges, and incubators. Cell culture equipment encompasses specialized tools and devices used to cultivate and maintain cells under controlled laboratory environments. This equipment incorporates various preparation methods, such as automated DMEM preparation, manual DMEM preparation, and hybrid DMEM preparation. Distribution channels include direct sales, online platforms, distributors, and resellers. The equipment is widely utilized in applications such as cell culture, tissue engineering, and drug development, serving end users including biotechnology and pharmaceutical companies, research and academic institutions, and contract research organizations (CROs).

The countries covered in the dulbecco’s modified eagle medium (DMEM) medium equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The dulbecco’s modified eagle medium (DMEM) medium equipment market consists of sales of water bath systems, micropipette controllers, CO₂ monitors, shakers and mixers, and sterile workstations. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.